EUVIMEDEUVIMED entdecken
Crossref

Dual-mechanism mucoadhesive hydrogel integrating pH-independent barriers and autophagy-driven immunotherapy for the treatment of ulcerative colitis

Jie Wang, Shenyuan Ouyang, Gaolong Lin, Dingwei Li, Bingyu Ding, Yumo Chen, Bingjie Tong, Ting Ouyang, Helin Xu, Wenzhi Wu

Acta Biomaterialia · 2025-10 · 205 · 302-318

DOI: 10.1016/j.actbio.2025.09.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-10. Verfasst von Jie Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; Departmen…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Autophagy, Hydrogels, Immunotherapy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Wenzhou Municipal Science and Technology Bureau, Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current therapies for ulcerative colitis (UC) face critical challenges, including systemic toxicity and inadequate mucosal regeneration. Herein, we present a pioneering dual-mechanism therapeutic platform integrating pH-independent acid-treated sucralfate (ASF) with autophagy-inducing spermidine (Spd) to synergistically address UC pathogenesis. Unlike conventional pH-dependent barrier therapies, ASF forms a mechanically tunable, injectable hydrogel that adheres robustly to colonic mucosa regardless of local pH. Spermidine was easily mounted into ASF hydrogel matrix via electrostatic interaction, with more than 90 % encapsulation efficiency. Moreover, the mechanical strength of ASF hydrogel was precisely modulated by adjusting spermidine amount in formula, making it suitable for effective gut mucosa coverage. Importantly, in vitro permeability test showed that spermidine-loaded ASF hydrogel (Spd-ASF) demonstrated the selective barrier functionality, blocking > 80 % of Escherichia coli and LPS penetration while allowing nutrient permeability. Moreover, micro-CT images demonstrated that rectally infused Spd-ASF hydrogel was uniformly adhered to the colon wall at least for 8 h. In DSS-induced colitis mice, rectally administrating Spd-ASF hydrogel uniquely restored colon length to near-normal levels (vs. 30 % shortening in controls), reduced proinflammatory cytokines (TNF-α, IL-6, IL-1β) by 60-75 %, and doubled goblet cell density. Mechanistically, Spd-ASF reprogrammed macrophage behavior by activating autophagy and enhancing efferocytosis, driving M2 polarization to resolve inflammation. Notably, Spd-ASF uniquely reversed dysbiosis, elevating beneficial Lactobacillus while suppressing colitis-associated Muribaculaceae and Clostridia. This study is the first to combine mucoadhesive biomaterial engineering with autophagy-mediated immunomodulation, offering a paradigm shift in UC therapy by simultaneously shielding the mucosa and reprogramming inflammatory pathways. STATEMENT OF SIGNIFICANCE: Here, autophagy-inducing spermidine (Spd) and pH-independent acid-treated sucralfate (ASF) were combined to create the novel dual-mechanism hydrogel (Spd-ASF), which works in concert to combat UC pathogenesis. The selective barrier functioning of Spd-ASF hydrogel was established by its capacity to permit nutritional permeability while preventing the transfer of toxins (LPS) and pathogenic bacteria (E. coli). Additionally, rectally infused Spd-ASF hydrogel was consistently attached on the colon wall for at least eight hours, as seen by micro-CT images. Spd-ASF therapy doubled the density of goblet cells, decreased proinflammatory cytokines (TNF-α, IL-6, and IL-1β) by 60-75 %, boosted helpful Lactobacillus, and lowered pathogenic Muribaculaceae and Clostridia. It also restored colon length in DSS-induced colitis animals. Spd-ASF's therapeutic action was closely linked to promoting cellular efferocytosis and triggering macrophage autophagy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeAutophagyHydrogelsImmunotherapyIntestinal MucosaAnimalsMiceHydrogen-Ion ConcentrationHumansSpermidineMice, Inbred C57BLMale

Stichwörter der Autor:innen

Acid-treated sucralfate coacervateAutophagyGut microbiota reprogrammingMacrophage efferocytosisMucosal barrierSpermidine

Substanzen

HydrogelsSpermidine

Autor:innen und Institutionen

  • Department of Gastroenterology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China; Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical…
  • Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou City, Zhejiang Province, 325035, China.
  • School of Traditional Chinese Medicine, Wenzhou Medical University, Wenzhou City, Zhejiang Province 325035, China.
  • Department of Pharmaceutics, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou City, Zhejiang Province, 325035, China. Electronic address: xhlpharm1214@126.com.
  • Department of Gastroenterology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou City, Zhejiang Province 325000, China. Electronic address: wwzljy@163.com.

Förderung

  • Wenzhou Municipal Science and Technology Bureau
  • Wenzhou Medical University

Zitieren

APA

Wang, J., Ouyang, S., Lin, G., Li, D., Ding, B., Chen, Y., Tong, B., Ouyang, T., Xu, H., & Wu, W. (2025). Dual-mechanism mucoadhesive hydrogel integrating pH-independent barriers and autophagy-driven immunotherapy for the treatment of ulcerative colitis. Acta Biomaterialia, 205, 302-318. https://doi.org/10.1016/j.actbio.2025.09.006

Vancouver

Wang J, Ouyang S, Lin G, Li D, Ding B, Chen Y, et al. Dual-mechanism mucoadhesive hydrogel integrating pH-independent barriers and autophagy-driven immunotherapy for the treatment of ulcerative colitis. Acta Biomaterialia. 2025;205:302-318. doi:10.1016/j.actbio.2025.09.006

BibTeX
@article{Wang2025,
  author = {Wang, Jie and Ouyang, Shenyuan and Lin, Gaolong and Li, Dingwei and Ding, Bingyu and Chen, Yumo and Tong, Bingjie and Ouyang, Ting and Xu, Helin and Wu, Wenzhi},
  title = {Dual-mechanism mucoadhesive hydrogel integrating pH-independent barriers and autophagy-driven immunotherapy for the treatment of ulcerative colitis},
  journal = {Acta Biomaterialia},
  year = {2025},
  volume = {205},
  pages = {302--318},
  doi = {10.1016/j.actbio.2025.09.006}
}
Kostenlos starten →